Accurate, reliable prediction of risk for Alzheimer's disease (AD) is essential for early, disease-43 modifying therapeutics. Multimodal MRI, such as structural and diffusion MRI, is likely to contain 44 complementary information of neurodegenerative processes in AD. Here we tested the utility of 45 the multimodal MRI (T1-weighted structure and diffusion MRI), combined with high-throughput 46 brain phenotyping-morphometry and structural connectomics-and machine learning, as a 47 diagnostic tool for AD. We used, firstly, a clinical cohort at a dementia clinic (National Health 48
There is an urgent, unmet need for clinically useful biomarkers of risk for Alzheimer's disease 78 (AD) based on non-invasive and affordable measures suited for routine examination of 79 individuals with subthreshold symptoms. Studies have focused on brain MRI-derived markers. 80 Cortical thinning and reduced hippocampal volumes based on structural MRI are known for 81 markers for AD, but these structural estimates alone are insufficient for implementation at 82 clinical settings because of insufficient accuracy and generalizability (Teipel et al., 2015) . 83 84 It is conceptualized that biomarkers of Aβ deposition become abnormal early, and then markers 85 of neuronal neurodegeneration or dysfunction show abnormality later in AD (Jack et al., 2010). 86
These markers of neurodegeneration, rather than those of Aβ or Tau proteinopathy, appear 87 directly related to cognitive symptoms (Jack et al., 2010). Neurobiology of AD relates to axonal 88 and neuronal degeneration followed by fibrillar lesions triggered by amyloid precursor protein 89 (APP)-initiated death-receptor mechanism and activation of tau (Holtzman et al., 2011; Nikolaev 90 et al., 2009). Initial axonal degeneration may lead to grey matter tissue changes and finally to 91 neuronal loss or atrophy resulting in cognitive and functional impairment. Since diffusion MRI 92 uses water molecules as an endogenous tracer to probe tissue microstructure or properties 93 (Beaulieu, 2002) , it can detect subtle changes in microstructure tissue properties in AD. 94 Previous studies have shown that decreased white matter integrity is associated with AD 95 ( , and mean length of streamlines given any two 179
brain regions based on multiple atlases. Diffusion-weighted magnetic resonance imaging (DWI) 180 was preprocessed using the following pipeline in MRtrix 3. DWI was first denoised using a novel 181 algorithm based on random matrix theory that permits data-driven, non-arbitrary threshold for 182
Principal Component Analysis denoising; this method enhances the DWI quality for quantitative 183 and statistical interpretation (Veraart et al., 2016). Denoised images then underwent eddy 184 current and motion correction (Andersson and Sotiropoulos, 2016), brain extraction from three 185 non-diffusion-weighted images (taking their median), and bias field correction using N4 186 algorithm (N4ITK), an improved N3 method, in Advanced Normalization Tools (ANTs) (Tustison 187 et al., 2010). We then estimated fiber orientation distributions from each preprocessed image 188 using 2 nd -order integration over fiber orientation distributions (iFOD2). Based on the FODs, 189
probabilistic tractography was performed using constrained spherical devolution (CSD). We 190 used a target streamline count of 10 million across the whole brain. The tractograms were 191 filtered using spherical-deconvolution informed filtering of tractograms (SIFT) with a target 192 streamline count of 3 million. After a primary statistical analysis using these filtered tractograms, 193
we tested whether the effects of interest were robust to the tractography and filtering 194 parameters, such as the target streamline count for tractography, SIFT, or a ratio between them. 195
This method permits mapping to streamline estimation back to individual's DWI and updating a 196 reconstruction to improve model fit. This approach renders the streamline counts connecting 197 two brain regions proportional to the total cross-sectional area of the white matter fibers 198 connecting those regions, enhancing streamline counts as a biologically plausible quantity, 199
representing "structural connectivity". This was done by repeating tractography and SIFT with a 200 set of extreme parameters (100 million and 5 million target streamlines, respectively) with a 201 filtering factor of 20 (100/5). Finally, from the filtered tractograms, we generated a connectivity 202 matrix in each participant using brain parcellation and segmentation obtained from structural 203 MRI from the same person. In this way, our structural connectome estimates reflect 204 individualized connectomes. We used two different atlases in Freesurfer ( Given our goal to compare the classifiers trained on the distinct multimodal brain 214 phenotypes ,rather than to find a novel machine learning algorithm, we used the following three 215 standard algorithms that have been extensively used in the literature ( 
RESULTS

262
Classification of AD and MCI 263
In the NHIS-IH Cohort, we tested machine learning classification using white matter structural 264 connectomes and morphometric estimates in 211 elders at the dementia clinic at the Korean 265
National Health Insurance Service Ilsan Hospital. Age and sex alone showed moderate 266 accuracies: AD/SMC: accuracy = 0.77; MCI/SMC: accuracy = 0.63; AD/MCI: accuracy = 0.72. 267
White matter hyperintensity (WMH) served as a benchmark model, for it has been widely tested 268 in the literature. 269 270
In classification of AD vs. SMC, optimal classification performance was shown in 271 "morphometry+connectome" model (accuracy = 0.97, 95% CI=0.95-0.98) and "connectome" 272 model (accuracy = 0.97, 95% CI=0.96-0.98) (Table 2; Figure 1A) . These two models 273 outperformed "morphometry" (accuracy = 0.87, 95% CI=0.85-0.88) and WMH benchmark 274 models (accuracy = 0.73, 95% CI=0.71-0.75). In classification of MCI vs. SMC, similar 275 classification performance was observed in "morphometry+connectome" (accuracy = 0.82, 95% 276
CI=0.80-0.85) and "connectome" models (accuracy = 0.83, 95% CI=0.81-0.85), compared with 277 lower performance of "morphometry" (accuracy = 0.59, 95% CI=0.57-0.60) and the WMH 278 benchmark models (accuracy = 0.57, 95% CI=0.54-0.60). In classification of AD vs. MCI, 279
"morphometry+connectome" models showed a best accuracy (accuracy=0.97, 95% CI=0.96-280 0.98), followed by "connectome" model (accuracy = 0.96, 95% CI=0.95-0.97), "morphometry" 281 model ( accuracy = 0.83, 95% CI=0.80-0.86), and the WMH benchmark models (accuracy = 282 0.66, 95% CI=0.64-0.69). Throughput all classifications, connectomes and morphometry 283 showed greater diagnostic accuracies compared with the WMH benchmark. 284 285
Testing generalizability 286 We next tested the generalizability of the same multimodal brain imaging-based machine 287 learning using ADNI-2 data. We included participants in ADNI-2 data whose structural and 288 diffusion MRI (baseline) were both collected . To compare the performance of our classifiers, we 289 used the invasive CSF biomarkers (p-tau, t-tau, Aβ42, p-tau/ Aβ42, t-tau/ Aβ42) as a benchmark 290 model. In the classification of AD vs. HC, all the MRI-based models showed similarly optimal 291 performance around 0.88 accuracy (Table 2; Figure 1B) , outperforming the CSF benchmark 292 model (accuracy = 0.75, 95% CI=0.73-0.77). In classification MCI vs. HC, all the MRI-based 293 models showed similar performance with accuracies ranging from 0.64-0.67, outperforming the 294 CSF benchmark (accuracy = 0.62, 95% CI=0.59-0.65). In classification AD vs. MCI, all the MRI-295 based models showed similar performance with accuracy ranging from 0.66-0.71, outperforming 296 the CSF benchmark (accuracy = 0.54, 95% CI=0.52-0.57) which is barely above chance. This 297 generalizability data showed, firstly, morphometry and connectome estimates showed equally 298 good performance consistently exceeding the invasive CSF biomarkers in classifying 299 AD/MCI/HC; secondly, unlike the NHIS-IH results, synergistic effects of combined morphometry 300 and connectomes were not observed using our machine learning framework. 301 302 303
Testing utility for prognosis 304 Of the ADNI-2 data, we further tested the utility of our approach in predicting the disease 305 trajectory. Data from 60 elders were used, whose baseline diagnosis was MCI and who were 306 followed for at least two years. Machine learning models trained on the same five CSF 307 benchmarks were used as a benchmark. In predicting progression from MCI to AD, 308 "morphometry" model showed a highest accuracy (accuracy = 0.69, 95% CI=0.65-0.73) among 309 MRI-based models, similar to the CSF benchmark model (accuracy = 0.70, 95% CI=0.66-0.75). 310 (Table 5, Figure 2) . "Connectome" model showed a lower, but statistically meaningful accuracy 311 (accuracy = 0.57, 95% CI=0.53-0.61). Combining the two modalities of morphometry and 312 connectomes ("morphometry+connectome") did not improve the prognosis accuracy (accuracy 313 = 0.59, 95% CI=0.56-0.62), compared with "morphometry" model. In this study, we used large-scale MRI-derived brain phenotypes (morphometry and white 319 matter structural connectomes) with machine learning techniques to test AD and MCI diagnosis 320 in two independent Alzheimer's disease datasets. We also predicted disease progression to AD 321 from MCI. For high-throughput imaging analysis, we used a well-established automated 322 pipeline for morphometry and a pipeline to estimate rigorously individualized white matter 323 structural connectomes. Firstly, the models trained on morphometry and connectomes showed 324 the best accuracy in classifying AD, MCI, and SMC or HC in the single-site data (ranging from 325 90% to 99% in AUC ROC; NHIS-IH, South Korea) as well as the multi-site (ranging from 70% to 326 97% in AUC ROC; ADNI-2, USA) "reproducibility" data. The models outperformed the 327 benchmark models significantly (e.g., white matter hyperintensity or CSF biomarkers) and 328 demographic model (including age, sex, and education). Second, the model trained on 329 connectome or morphometric estimates showed moderate accuracies (ranging from 57% to 330 79%; AUC) in predicting progression to AD in 60 elders with MCI in ADNI-2 data. These results 331
show the utility of white matter structural connectomes in addition to morphometry in detecting 332 the abnormal brain aging process in AD pathology. 333 334
A novel aspect of this study is to assess the utility of the dMRI-based white matter structural 335 connectomes in predictive modeling of AD in a sufficiently large sample (n=211) and to validate 336 it in an independent cohort (n=179). In the NHIS-IH data, the "connectome" model and 337
" properties, namely volumes. However, this pattern is not seen in the ADNI-2 multi-site data; this 359 leads to an issue of data harmonization to deal with site effects of MRI-derived estimates. 360
361
The connectome or combined model shows ~10% decrease in model performance in the ADNI-362 2 multi-site data compared with the NHIS-IH single-site data. It is possible that it is related to the 363 site variability in the dMRI data. Indeed, prior studies show persistent inter-site variability in 364 diffusion data even when using similar types of scanners, pulse sequences or same field 365 strength (Fox et al., 2012; Mirzaalian et al., 2016) . This is a non-trivial problem because there 366 are hardly any objective ways to assess harmonization of dMRI data (e.g., a dynamic phantom 367 optimized for dMRI). One potential way to mitigate this variability issue across multiple data 368 sources is an analytical solution. A recent study suggests an elegant Bayesian method for post-369 acquisition harmonization of dMRI (Fortin et al., 2017). In our study, however, this method could 370 not be applied to our raw dMRI or fiber orientation distribution maps for probabilistic 371 tractography. 372 373
One potential approach to MRI harmonization is domain-invariant machine learning. 374
A recent seminal study (Ghafoorian et al., 2017) of white matter hyperintensity segmentation in 375 the brain shows a successful application of "multi-source domain adaption". That is, a 376 convolutional neural network trained on data from a single domain (i.e., from a single scanner 377 with a single acquisition protocol) was successfully applied (retrained) to the same task with 378 independent MRI from different domains (i.e., different acquisition protocols and image 379 dimension from the same scanner). Given the recent rapid development of the deep learning 380 algorithms, Artificial Intelligence-based domain adaptation might be a promising way towards 381 the generalizable and reproducible MRI-based analytics. 382 383
In predicting MCI-to-AD progression in the ADNI-2 data, the morphometry model outperforms 384
both connectome and combined models. This may first suggest that grey matter morphometry 385 provides more useful information in predicting the AD trajectory than the connectome measures. 386
However, given the smaller sample size (N=60) compared with AD/MCI classification (N=119), 387
in this analysis we suspect that machine learning training and feature selection may be 388 suboptimal for the connectome model than for the morphometry model, because of the 389 significantly large number of features in the former (N=33,698) than the latter (N=948). Similarly, 390 while the morphometry model and connectome model respectively showed statistically 391 meaningful (above chance) predictions, when combined, there was little improvement in model 392
performance. This indicates more rigorous methods to combine models trained across 393 multimodal brain imaging-derived phenotypes may be required, such as ensemble methods 394
(Zhang et al., 2011). 395 396
Limitations related to the NHIS-IH data include the significantly greater age in the AD group 397 compared with the MCI or SMC groups. It is possible that a greater aging effect embedded on 398 the brain phenotypes may have made the classification of AD easier. However, in ADNI data 399 with the age-matched samples, classification performance (AUC=0.97) was only slightly less 400 than the NHIS-IH data (AUC=0.99). This suggests that the patterns extracted from morphometry 401 and white matter connectomes may be specific to AD rather than an age-related bias. Another 402 limitation is the lack of healthy controls in the NHIS-IH cohorts. In this retrospective cohort at the 403 dementia clinic, individuals with Subjective Memory Complaints are cognitively normal. 404
Nevertheless, this group might not be equivalent to healthy controls as in the ADNI data. For 405 example, there might be subtle differences in brain health status between health individuals and 406 cognitively normal individuals with subjective memory complaints. Our study provides no data to 407 address this. Nevertheless, given the fact that in clinical settings, individuals seek for clinical 408 service usually when they suspect symptoms, our results of classifying AD and MCI from 409 individuals with SMC may have a unique clinical utility in addition to the comparisons of AD and 410 MCI with healthy controls in the ADNI data. 411 412
In sum, this study lends support for the individualized white matter structural connectomes, 413 estimated from multimodal MRI (structural and diffusion), in combination with machine learning 414 techniques, as a useful method to detect accurately AD-related neurodegeneration across the 415 whole brain in a data-driven manner. 416 Health Insurance Ilsan Hospital data).It showed higher diagnostic accuracy (area under the 503 curve of the receiver-operator characteristics or AUC ROC) of the machine learning model 504 trained on combined connectome and morphometric estimates consistently, compared with the 505 benchmark model trained on white matter hyperintensity. Out of three machine learning 506 algorithms (random forest, support vector machine, and logistic regression), best models were 507
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shown. Panel (B), classification performances in the ADNI-2 Cohort. It showed reproducible 508 results of diagnostic accuracy of connectomes and morphometry. The combined models show 509 better performance in predicting AD from healthy controls and AD from MCI, and similar in 510 predicting MCI from HC. Best models were shown. Compared with the NHIS-IH Cohort, the 511 reproducibility data shows less diagnostic accuracy presumably due to multiple sites and stricter 512 inclusion and exclusion criteria in ADNI. WMH, white matter hyperintensity; Demo, 513 demographics including sex, age, and education. 514 515 516 517 518 519
Figure 2. Prediction of progression to AD from MCI using connectomes and 521
morphometric estimates. Using ADNI-2 data that has follow-up data after baseline MRI scan, 522 machine learning models were tested using connectome and morphometry estimates to predict 523 MRI-to-AD progression in 60 elders with MCI (mean follow-up years in stable MCI, 3.76 ± 0.98; 524 range, 2.18-5.32). Morphometry model showed similar performance to CSF benchmark model. 525
Both the combined model and connectome model showed lower but meaningful accuracy. 526 527 528
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